Sharepoint Solutions
PRODUCTS
-
Applying experience, knowledge, and insights to plan and implement regulatory strategies for successful interactions with the FDA, MHRA, EMA, and other Global Regulatory Agencies.
-
Ready to go deeper on cell characterization? Advance past typical cell and donor screening to create a comprehensive immune cell profile for each donor as well as an assessment of the metabolic and effector potential of their cells. See beyond surface markers too.
-
Kneat enables regulated companies to consolidate validation and quality management into a single end-to-end web-based software platform.
CAI’s Kneat: Project-Ready allows your company to utilize a validated Kneat instance to execute your projects without start-up and on-going maintenance. Project-Ready does the heavy lifting for you with pre-designed processes and templates.
-
Early Phase Experts
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
With a broad range of experience delivering Phase 1 Healthy Volunteer, First in Human, First in Patient and Phase 2 trials, we know just how important it is for your asset to succeed in the early development lifecycle. Our experienced team will help you obtain high-quality data that will appeal to future investors, meet the requirements of international regulatory bodies such as the FDA, EMA, PMDA, and Health Canada, and prepare your product for larger Phase 3 and 4 studies, partnerships, licensing, and sale.
Whatever your clinical trial needs, we can provide a flexible, bespoke solution that will not only meet your regulatory requirements but also position your product for commercial success.
-
With 30+ years of experience in viral vector development and manufacturing, we bring unmatched expertise as your trusted CDMO for AAV. From plasmids to fill/finish and advanced analytics, we provide true end-to-end support, accelerating your path to the clinic and beyond.
WHITE PAPERS AND CASE STUDIES
-
FDA Recommendations For Gene Therapy For PMDs
Explore insight into the strategies and FDA recommendations for executing gene therapy development programs, specifically for primary mitochondrial diseases (PMDs).
-
The State Of Global Clinical Trial Disclosure
See what industry organizations are saying about trial transparency, regulations by region, what penalties are on the books, and whether they are enforced.
-
Fortrea Optimizes Site Matching On Retina Clinical Trials
Faced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.
-
Biotechnology Manufacturing Program Management
Find out how a global biotechnology manufacturing company executing several interrelated projects achieved critical project objectives while adhering to schedule and financial commitments.
-
Selecting A New Sporicidal Disinfectant: What The Cleanroom Manager Needs To Know
This guide helps cleanroom managers evaluate sporicides by efficacy, safety, and compatibility to ensure contamination control without compromising operational integrity.
-
Stopper Migration In Frozen Pre-Filled Syringes
Review a semi-automated method for dynamically assessing plunger migration under controlled variations in temperature and pressure, utilizing computer vision tools.
-
PEG In LNP Formulations: Addressing Challenges And Seeking Solutions
Polyethylene glycol and similar variants have driven innovative research for therapies. However, the continued use of PEG poses significant drawbacks.
-
De-Risking Preclinical Candidates With Predictive Immunotoxicology
From target engagement and mechanism of action to efficacy and prediction of adverse immune reactions, immunology assays deliver data that reduce your risk of failing later.
-
Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
CDMO Accelerates Contract Manufacturing With Electronic Batch Records
A prominent CDMO sought a specialized software solution to streamline and accelerate its manufacturing processes, enabling the efficient production of complex, customized products in record time.
-
Gateways To Asia: Market Access In Japan And South Korea
Learn how the recent developments in market access and regulatory rules in Japan and South Korea have paved the way for expansion in Asia.
-
Six Strategies For Accelerating Approval For Cell And Gene Therapies
As you advance through the evolving regulatory landscape for cell and gene therapies, review these six proven strategies to help sponsors reduce their risk of failure and expedite speed to market.
NEWS
-
EPA Announces $268M WIFIA Loan For Substantial Water Reuse Project In Virginia10/24/2024
Today, the U.S. Environmental Protection Agency announced a $268M Water Infrastructure Finance and Innovation Act (WIFIA) loan to Hampton Roads Sanitation District (HRSD), which serves areas across southeast Virginia and the Eastern Shore.
-
Biden-Harris Administration Announces Over $125M For Georgia Drinking Water, Wastewater And Stormwater Infrastructure Upgrades As Part Of President Biden's Investing In America Agenda2/23/2024
The U.S. Environmental Protection Agency (EPA) announced over $125M from President Biden’s Investing in America agenda for Georgia drinking water and clean water infrastructure upgrades.
-
NEW Group Itinerary Builder Developed By UrVenue + Club Med To Debut At HITEC6/24/2024
A new tool developed by UrVenue and Club Med will be unveiled this week at HITEC, held now through June 27 at the Charlotte (N.C.) Convention Center
-
WRF Seeks Pre-proposals For High-Priority Utility Research2/15/2024
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program. The Tailored Collaboration Program provides an opportunity for WRF subscribers to partner with WRF on projects that address issues of interest to a significant subgroup of subscribers.
-
Biden-Harris Administration Announces Over $20M For Commonwealth Of The Northern Mariana Islands Drinking Water, Wastewater, And Stormwater Infrastructure Upgrades As Part Of President Biden's Investing In America Agenda2/20/2024
Today, the U.S. Environmental Protection Agency (EPA) announced over $20M ($20,022,000) from President Biden’s Investing in America agenda for Commonwealth of the Northern Mariana Islands (CNMI) drinking water and clean water infrastructure upgrades.